These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study. Brodde OE, Nagel M, Schümann HJ. Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409 [Abstract] [Full Text] [Related]
9. Pharmacological and metabolic interactions between ethanol and the dopamine-beta-hydroxylase inhibitor FLA 63 in mice. Sharkawi M. Neuropharmacology; 1980 Mar; 19(3):277-80. PubMed ID: 6999373 [No Abstract] [Full Text] [Related]
10. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia. Dolphin A, Jenner P, Marsden CD. Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534 [No Abstract] [Full Text] [Related]
11. Studies on memory: the cerebral spread of an engram in mice as affected by inhibitors of dopamine beta-hydroxylase. Flexner JB, Flexner LB, Church AC. Pharmacol Biochem Behav; 1983 Apr; 18(4):519-23. PubMed ID: 6867057 [Abstract] [Full Text] [Related]
12. Role of the biogenic amines in the reversal of cycloheximide-induced amnesia. Quartermain D, Botwinick CY. J Comp Physiol Psychol; 1975 Jan; 88(1):386-401. PubMed ID: 235572 [Abstract] [Full Text] [Related]
13. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats. Tottmar O, Hellström E, Holmberg K, Lindros KO. Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724 [Abstract] [Full Text] [Related]
14. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine. Evans KR, Beninger RJ, Eikelboom R. Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764 [Abstract] [Full Text] [Related]
15. The anticonvulsant action of methazolamide in mice: antagonism by various inhibitors of dopamine beta-hydroxylase. Lotti VJ, Torchiana ML, Stone CA. Eur J Pharmacol; 1977 Aug 15; 44(4):387-90. PubMed ID: 19268 [Abstract] [Full Text] [Related]
17. Proceedings: Influence of H44/68 and FLA63 on central catecholamines and motor activity under light and darkness. Lemmer B, Berger T. Naunyn Schmiedebergs Arch Pharmacol; 1975 Sep 15; 287 Suppl():R13. PubMed ID: 238144 [No Abstract] [Full Text] [Related]
18. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice. Ross SB, Ogren SO. J Pharm Pharmacol; 1976 Jul 15; 28(7):590-2. PubMed ID: 8618 [No Abstract] [Full Text] [Related]
19. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain. Wise CD, Belluzzi JD, Stein L. Pharmacol Biochem Behav; 1977 Dec 15; 7(6):549-53. PubMed ID: 201940 [Abstract] [Full Text] [Related]
20. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats. Kun I. Endocrinologie; 1978 Dec 15; 16(4):263-8. PubMed ID: 569899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]